These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 12060981

  • 21. [Prognostic value of the initial response to corticosteroids for children with acute lymphoblastic leukemia].
    Klimza MJ, Sońta-Jakimczyk DJ.
    Wiad Lek; 2005; 58(11-12):622-5. PubMed ID: 16594471
    [Abstract] [Full Text] [Related]

  • 22. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.
    Aricò M, Valsecchi MG, Rizzari C, Barisone E, Biondi A, Casale F, Locatelli F, Lo Nigro L, Luciani M, Messina C, Micalizzi C, Parasole R, Pession A, Santoro N, Testi AM, Silvestri D, Basso G, Masera G, Conter V.
    J Clin Oncol; 2008 Jan 10; 26(2):283-9. PubMed ID: 18182669
    [Abstract] [Full Text] [Related]

  • 23. [Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)].
    Riehm H, Reiter A, Schrappe M, Berthold F, Dopfer R, Gerein V, Ludwig R, Ritter J, Stollmann B, Henze G.
    Klin Padiatr; 1987 Jan 10; 199(3):151-60. PubMed ID: 3306129
    [Abstract] [Full Text] [Related]

  • 24. Extended triple intrathecal therapy in children with T-cell acute lymphoblastic leukaemia: a report from the Israeli National ALL-Studies.
    Stark B, Avrahami G, Nirel R, Abramov A, Attias D, Ballin A, Bielorai B, Burstein Y, Gavriel H, Elhasid R, Kapelushnik J, Sthoeger D, Toren A, Wientraub M, Yaniv I, Izraeli S.
    Br J Haematol; 2009 Oct 10; 147(1):113-24. PubMed ID: 19694717
    [Abstract] [Full Text] [Related]

  • 25. Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy.
    Pichler H, Möricke A, Mann G, Teigler-Schlegel A, Niggli F, Nebral K, König M, Inthal A, Krehan D, Dworzak MN, Janousek D, Harbott J, Schrappe M, Gadner H, Strehl S, Haas OA, Panzer-Grümayer R, Attarbaschi A, Berlin-Frankfurt-Münster (BFM) Study Group.
    Br J Haematol; 2010 Apr 10; 149(1):93-100. PubMed ID: 20067563
    [Abstract] [Full Text] [Related]

  • 26. Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.
    Eckert C, von Stackelberg A, Seeger K, Groeneveld TW, Peters C, Klingebiel T, Borkhardt A, Schrappe M, Escherich G, Henze G.
    Eur J Cancer; 2013 Apr 10; 49(6):1346-55. PubMed ID: 23265714
    [Abstract] [Full Text] [Related]

  • 27. [Preliminary results of the use of MRD test among children with acute lymphoblastic leukaemia].
    Raciborska A, Wypych A, Rokicka-Milewska R, Siedlecki JA, Kulik J.
    Przegl Lek; 2004 Apr 10; 61 Suppl 2():62-6. PubMed ID: 15686049
    [Abstract] [Full Text] [Related]

  • 28. Minimal residual disease-guided treatment deintensification for children with acute lymphoblastic leukemia: results from the Malaysia-Singapore acute lymphoblastic leukemia 2003 study.
    Yeoh AE, Ariffin H, Chai EL, Kwok CS, Chan YH, Ponnudurai K, Campana D, Tan PL, Chan MY, Kham SK, Chong LA, Tan AM, Lin HP, Quah TC.
    J Clin Oncol; 2012 Jul 01; 30(19):2384-92. PubMed ID: 22614971
    [Abstract] [Full Text] [Related]

  • 29. The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment-related mortality and not an increased relapse rate--a population-based analysis of 25 years of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
    Pichler H, Reismüller B, Steiner M, Dworzak MN, Pötschger U, Urban C, Meister B, Schmitt K, Panzer-Grümayer R, Haas OA, Attarbaschi A, Mann G, Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
    Br J Haematol; 2013 May 01; 161(4):556-65. PubMed ID: 23480776
    [Abstract] [Full Text] [Related]

  • 30. Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group.
    Seidemann K, Tiemann M, Lauterbach I, Mann G, Simonitsch I, Stankewitz K, Schrappe M, Zimmermann M, Niemeyer C, Parwaresch R, Riehm H, Reiter A, NHL Berlin-Frankfurt-Münster Group.
    J Clin Oncol; 2003 May 01; 21(9):1782-9. PubMed ID: 12721255
    [Abstract] [Full Text] [Related]

  • 31. Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma.
    Burkhardt B, Woessmann W, Zimmermann M, Kontny U, Vormoor J, Doerffel W, Mann G, Henze G, Niggli F, Ludwig WD, Janssen D, Riehm H, Schrappe M, Reiter A.
    J Clin Oncol; 2006 Jan 20; 24(3):491-9. PubMed ID: 16421426
    [Abstract] [Full Text] [Related]

  • 32. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.
    Seidemann K, Zimmermann M, Book M, Meyer U, Burkhardt B, Welte K, Reiter A, Stanulla M.
    J Clin Oncol; 2005 Nov 20; 23(33):8414-21. PubMed ID: 16293872
    [Abstract] [Full Text] [Related]

  • 33. [Treatment of acute lymphoblastic leukemia in children according to the ALL-BFM-90m protocol in the Russian Federation and the Republic of Belarus].
    Miakova NV, Aleĭnikova OV, Hartmann R, Rudneva AE, Trubina NM, Fechina LG, Timakov AM, Shamardina AV, Lebedev VV, Varfolomeeva SIu, Dudkin SD, Dyshlevaia ZM, Timofeeva VN, Rumiantsev AG, Henze H, Karachunskiĭ AI.
    Vopr Onkol; 2002 Nov 20; 48(3):347-51. PubMed ID: 12455360
    [Abstract] [Full Text] [Related]

  • 34. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol.
    Bajel A, George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M.
    Pediatr Blood Cancer; 2008 Nov 20; 51(5):621-5. PubMed ID: 18688848
    [Abstract] [Full Text] [Related]

  • 35. Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia.
    Paganin M, Zecca M, Fabbri G, Polato K, Biondi A, Rizzari C, Locatelli F, Basso G.
    Leukemia; 2008 Dec 20; 22(12):2193-200. PubMed ID: 18754029
    [Abstract] [Full Text] [Related]

  • 36. Risk-adapted stratification and treatment of childhood acute lymphoblastic leukaemia.
    Schrappe M.
    Radiat Prot Dosimetry; 2008 Dec 20; 132(2):130-3. PubMed ID: 19017727
    [Abstract] [Full Text] [Related]

  • 37. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Skoczeń S, Balwierz W, Moryl-Bujakowska A, Pawińska K, Luszczyńska A, Balcerska A, Płoszyńska A, Chybicka A, Dobaczewski G, Juszczak K, Wachowiak J, Derwich K, Kowalczyk J, Wiśniewska-Slusarz H, Matysiak M, Krauze A, Pawelec K, Sońta-Jakimczyk D, Tomaszewska R, Wysocki M, Styczyńskii J, Swiatkiewicz V, Polish Pediatric Leukemia/Lymphoma Study Group.
    Przegl Lek; 2006 Dec 20; 63(1):11-4. PubMed ID: 16892892
    [Abstract] [Full Text] [Related]

  • 38. Prospective use of molecular minimal residual disease for risk stratification in children and adolescents with acute lymphoblastic leukemia : Long-term results of the AIEOP-BFM ALL 2000 trial in Austria.
    Ronceray L, Dworzak M, Dieckmann K, Ebetsberger-Dachs G, Glogova E, Haas OA, Jones N, Nebral K, Moser R, Lion T, Meister B, Panzer-Grümayer R, Strehl S, Peters C, Pötschger U, Urban C, Mann G, Attarbaschi A, Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
    Wien Klin Wochenschr; 2024 Jul 20; 136(13-14):405-418. PubMed ID: 37535134
    [Abstract] [Full Text] [Related]

  • 39. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Mora J, Filippa DA, Qin J, Wollner N.
    Cancer; 2003 Sep 15; 98(6):1283-91. PubMed ID: 12973853
    [Abstract] [Full Text] [Related]

  • 40. Clinical outcome of patients with childhood acute lymphoblastic leukaemia and an initial leukaemic blood blast count of less than 1000 per microliter.
    Lauten M, Stanulla M, Zimmermann M, Welte K, Riehm H, Schrappe M.
    Klin Padiatr; 2001 Sep 15; 213(4):169-74. PubMed ID: 11528550
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.